Kyverna Therapeutics, Inc. share price logo

Kyverna Therapeutics, Inc.

NASDAQ: KYTX

Small Cap

$6.39

+0.21

(+3.40%)

as on

Kyverna Therapeutics, Inc. Stock Performance

as on October 12, 2026 at 2:16 pm IST

  • Day's Low

    Day's High

    $6.17
    $6.58
    downward going graph

    3.44%

    Downside

    2.97%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $5.96
    $13.67
    downward going graph

    6.73%

    Downside

    113.93%

    Upside

    downward going graph

Kyverna Therapeutics, Inc. share price movements today

Previous Close
$6.18
Open
$6.21
Volume
966.2K
Market Cap
$395.2M
Day's Low - High
$6.17 - $6.58
52 Week Low - High
$5.96 - $13.67

Kyverna Therapeutics, Inc. Historical Returns

1 Month Return
-11.98 %
3 Month Return
-24.69 %
1 Year Return
-3.62 %
3 Year Return
0 %
5 Year Return
0 %

Kyverna Therapeutics, Inc. Stock Fundamentals & Key Indicators

Check Kyverna Therapeutics, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$395.2M

EPS (TTM)

-2.94

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-2.17

Industry PE ratio

-6.44

PEG Ratio

-0.10

EBITDA

-149.3M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

-81.91%

Kyverna Therapeutics, Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Kyverna Therapeutics, Inc. with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Kyverna Therapeutics, Inc. image
Kyverna Therapeutics, Inc.
Buy$395.2MNA-2.170.00%0.00%
Moderna image
Moderna
Neutral$89.8B-27.68%-28.20-12.57%0.00%
Vertex Pharmaceuticals image
Vertex Pharmaceuticals
StrongBuy$129.3B183.05%29.4586.04%0.00%
Regeneron image
Regeneron
Buy$76.9B37.12%17.8384.86%0.50%

Stock Returns calculator for Kyverna Therapeutics, Inc. Stock including INR - Dollar returns

The Kyverna Therapeutics, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

Kyverna Therapeutics, Inc. investment value today

Current value as on today

₹1,04,092

Returns

₹4,092

(+4.09%)

Returns from Kyverna Therapeutics, Inc. Stock

-₹3,620 (-3.62%)

Dollar Impact

₹7,712 (+7.71%)

Analyst Recommendation on Kyverna Therapeutics, Inc. Stock

Based on 2 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 2 analysts, 100% of analysts recommend a 'BUY' rating for Kyverna Therapeutics, Inc.. Average target price of $30.4

Kyverna Therapeutics, Inc. Share Price Target

Get share price movements and forecasts by analysts on Kyverna Therapeutics, Inc..

What analysts predicted

78.98%UPSIDE

Target Price

$30.4

Current Price

$6.39

Analyzed by

2 Analysts

High

$33

Target

$30.40

Low

$25

Kyverna Therapeutics, Inc. target price $30.4, a slight upside of 78.98% compared to current price of $6.39. According to 2 analysts rating.

Indian Investors' Interest in Kyverna Therapeutics, Inc. Stock

Search interest for Kyverna Therapeutics, Inc. Stock has increased by 33% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:33% versus previous 30 day period

Kyverna Therapeutics, Inc. Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
-
-
-
-
-
-
-
-
-
-
Gross Profit
0
-
-29
0
0
0
-
-
0
-
Operating Income
0
-33
-38
-41
-47
-44
-38
-39
-41
-39
EBITDA
0
-28
-36
-36
-44
-41
-36
-36
-38
-37
Interest Expense
0
0
0
0
0
0
0
0
0
0
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
0
-28
-34
-37
-44
-42
-36
-37
-39
-38
Income Tax Expense
-
-
-
-
-
-
-
-
-
-
Net Income
0
-28
-34
-37
-44
-42
-36
-37
-39
-38
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Kyverna Therapeutics, Inc. Annual Profit & Loss

All numbers in Millions USD

Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
5
7
-
-
-
Gross Profit
5
7
-1
-2
-
Operating Income
-26
-29
-62
-142
-169
EBITDA
-25
-27
-58
-125
-159
Interest Expense
0
0
0
0
0
Depreciation
0
1
1
2
1
Income Before Tax
-26
-28
-60
-127
-161
Income Tax Expense
-
-
-
-
-
Net Income
-26
-28
-60
-127
-161
Net Profit Margin
100.00%
100.00%
0.00%
0.00%
0.00%

Kyverna Therapeutics, Inc. Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-26
-28
-34
-37
-44
-42
-36
-37
-39
-38
Operating Cash Flow
-25
-24
-27
-37
-44
-31
-43
-33
-41
-40
Investing Cash Flow
-122
-67
0
29
5
29
22
-17
-50
36
Financing Cash Flow
338
0
0
0
0
0
1
140
0
3
Change in Cash
189
-92
-26
-8
-39
-3
-19
89
-91
0

Kyverna Therapeutics, Inc. Annual Cash Flow

All numbers in Millions USD

Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-26
-28
-60
-127
-161
Operating Cash Flow
-22
-36
-52
-114
-153
Investing Cash Flow
-1
-14
-8
-160
40
Financing Cash Flow
72
11
58
337
141
Change in Cash
49
-38
-3
61
27

Global Institutional Holdings in Kyverna Therapeutics, Inc.

Check out the Institutions with significant holdings in Kyverna Therapeutics, Inc..

Funds
Holdings
Vanguard
3.55%
iShares
3.29%
James E. Flynn
3.23%
VANGUARD INDEX FUNDS
2.82%
T. ROWE PRICE HEALTH SCIENCES FUND, INC.
1.85%
See all

Kyverna Therapeutics, Inc. News & Key Events

  • img

    Today's Timeline - 24 September

    Thu, 04:01 PM

    -

    Kyverna reports positive one-year data for miv-cel in stiff person syndrome, supporting BLA submission by Q4 2026.

Insights on Kyverna Therapeutics, Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, KYTX stock has moved up by 1.1%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 738.6% return, outperforming this stock by 742.2%

About Kyverna Therapeutics, Inc.

Kyverna Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing cell therapies for patients with autoimmune diseases. Its lead product candidate is KYV-101, an autologous CD19 CAR T-cell product candidate for the treatment of stiff person syndrome, myasthenia gravis, and lupus nephritis, as well as multiple sclerosis and systemic sclerosis. The company is also developing KYV-102, an autologous CD19 CAR T-cell product candidate with whole blood rapid manufacturing; and KYV-201, an allogeneic CD19 CAR T-cell product candidate. It has a license and collaboration agreement with Intellia Therapeutics, Inc. to research and develop an allogeneic CD19-directed CAR cell therapy product. The company was formerly known as BAIT Therapeutics, Inc. and changed its name to Kyverna Therapeutics, Inc. in October 2019. Kyverna Therapeutics, Inc. was incorporated in 2018 and is headquartered in Emeryville, California.
OrganisationKyverna Therapeutics, Inc.
Headquarters5980 Horton Street, Emeryville, CA, 94608, US
IndustryBiotechnology
CEOWarner Biddle

Key Management of Kyverna Therapeutics, Inc.

Name

Title

Dr. Tom Van Blarcom Ph.D.

Senior VP & Head of Research

Mr. Mayo Pujols

Chief Technology Officer

Ms. Jessica Serra

Head of Investor Relations

Mr. Ritesh Srivastava

Chief Legal & Compliance Officer

Ms. Christi L. Shaw

Executive Chairperson

Mr. Warner Biddle

CEO & Director

Dr. Naji H. Gehchan M.B.A., M.D.

Chief Medical & Development Officer

Mr. Gregory Martini

Chief Financial Officer

FAQs

What is Kyverna Therapeutics, Inc. share price today?

Kyverna Therapeutics, Inc. share price today is $6.39 as on at the close of the market. Kyverna Therapeutics, Inc. share today touched a day high of $6.58 and a low of $6.17.

What is the 52 week high and 52 week low for Kyverna Therapeutics, Inc. share?

Kyverna Therapeutics, Inc. share touched a 52 week high of $13.67 on and a 52 week low of $5.96 on . Kyverna Therapeutics, Inc. stock price today i.e. is closed at $6.39,which is 53.26% down from its 52 week high and 7.21% up from its 52 week low.

What is Kyverna Therapeutics, Inc.'s market capitalisation today?

Kyverna Therapeutics, Inc. market capitalisation is $0.00T as on .

How to invest in Kyverna Therapeutics, Inc. Stock (KYTX) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Kyverna Therapeutics, Inc. on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Kyverna Therapeutics, Inc. Stock (KYTX) from India?

Indian investors can start investing in Kyverna Therapeutics, Inc. (KYTX) shares with as little as ₹95.76000213623047 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹957.60 in Kyverna Therapeutics, Inc. stock (as per the Rupee-Dollar exchange rate as on ). Based on Kyverna Therapeutics, Inc. share’s latest price of $6.39 as on October 12, 2026 at 8:46 am IST, you will get 1.5649 shares of Kyverna Therapeutics, Inc.. Learn more about fractional shares .